Sarfez Pharmaceuticals, Inc.
🇺🇸United States
A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Sarfez Pharmaceuticals, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT06708611
- Locations
- 🇺🇸
Future Life Clinical Trials, Miami, Florida, United States
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Sarfez Pharmaceuticals, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06206512
- Locations
- 🇺🇸
Cardiometabolic Research Unit, Dallas, Texas, United States
Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-20
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Sarfez Pharmaceuticals, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT06176794
- Locations
- 🇺🇸
Division of Nephrology, Hypertension & Renal Transplantation, University of Florida, Gainesville, Florida, United States
Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide
Phase 1
Completed
- Conditions
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Sarfez Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03509545
- Locations
- 🇮🇳
Syngene International, Bangalore, Karnataka, India
A Food Effect Study of 60mg ER Torsemide
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-07-12
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Sarfez Pharmaceuticals, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT03215875
- Locations
- 🇮🇳
I.E.C. Consultants, Bangalore, India
Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-07-12
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Sarfez Pharmaceuticals, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03214874
- Locations
- 🇮🇳
I.E.C. Consultants, Bangalore, India
© Copyright 2024. All Rights Reserved by MedPath